Eli Lilly (LLY) EBITDA Margin (2009 - 2026)
Eli Lilly (LLY) recorded EBITDA Margin of 54.65% in Q3 2026, up 6.41 percentage points from 48.24% a year earlier and up 1.17 percentage points from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EBITDA Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Eli Lilly's EBITDA Margin came in at 52.18% as of Sep 30, 2026, up 5.83 percentage points year-over-year; for FY2025, it was 47.88%, up 8.04 percentage points from FY2024.
- Annual EBITDA Margin has increased for four straight years, with a five-year change of +14.66 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 39.84% in FY2024 (+5.31 pp), 34.53% in FY2023 (+1.04 pp), 33.49% in FY2022 (+2.15 pp) and 31.34% in FY2021 (-1.88 pp).
- The Q3 2026 figure is the highest quarterly EBITDA Margin in data going back to Q1 2009.
- On a year-over-year basis, EBITDA Margin has increased for 14 consecutive quarters, with an average year-over-year change of +7.14 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 11.78 percentage points in Q1 2022, against a drop of 10.30 percentage points in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 53.49% (Q2 2026), 50.55% (Q1 2026) and 49.19% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 22.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 54.65% |
| Jun 30, 2026 | 53.49% |
| Mar 31, 2026 | 50.55% |
| Dec 31, 2025 | 49.19% |
| Sep 30, 2025 | 48.24% |
| Jun 30, 2025 | 48.20% |
| Mar 31, 2025 | 45.02% |
| Dec 31, 2024 | 43.03% |
| Sep 30, 2024 | 42.13% |
| Jun 30, 2024 | 37.90% |
| Mar 31, 2024 | 34.44% |
| Dec 31, 2023 | 36.32% |
| Sep 30, 2023 | 40.39% |
| Jun 30, 2023 | 31.15% |
| Mar 31, 2023 | 28.18% |
| Dec 31, 2022 | 33.57% |
| Sep 30, 2022 | 30.28% |
| Jun 30, 2022 | 30.82% |
| Mar 31, 2022 | 38.48% |
| Dec 31, 2021 | 35.01% |
API Access
Eli Lilly EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();